Profilo
Christopher Jordan worked as Vice President-Regulatory Affairs at Endocyte, Inc. from 2018 to 2019.
He completed his graduate degree at George Washington University and his undergraduate degree at Purdue University.
Precedenti posizioni note di Christopher Jordan
| Società | Posizione | Fine |
|---|---|---|
| ENDOCYTE, INC. | Consigliere Generale | 01/12/2019 |
Formazione di Christopher Jordan
| Purdue University | Undergraduate Degree |
| George Washington University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
- Borsa valori
- Insiders
- Christopher Jordan
